Board of Directors

Dr. Matthias Kromayer, Chairman of the board

  • Member of the Board of Directors, MiG AG, München

Bernd von Polheim, Deputy chairman of the board

  • Managing Director, GN Hearing, Münster
  • Former VP GE Healthcare Europe

Matthias Guth

  • Investment Manager, MiG AG, München

Dierk Neugebauer

  • Director Market Access, Member of the Executive Board, Bristol-Myers Squibb GmbH & Co. KGaA

Thomas Raab

Dr. Bryan Olin

  • Vice President, Clinical, Quality and Regulatory Cyberonics, Inc., Houston, Texas U.S.A.


Do you have questions regarding NEMOS® and t-VNS® therapy? Please get in touch with us.

Please note: NEMOS® is not cleared or approved for use in the U.S.